Adalta Capital Management LLC Bristol Myers Squibb CO Transaction History

Adalta Capital Management LLC

$166 Million
Q2 2024

A detailed history of Adalta Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Adalta Capital Management LLC holds 18,877 shares of BMY stock, worth $1.03 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

18,877

Previous 18,877 -0.0%

Holding current value

$1.03 Million

Previous $1.02 Million 23.46%

% of portfolio

0.47%

Previous 0.62%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $2,399 - $2,720	-50 Reduced 0.26%	18,877 $1.02 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $7,999 - $9,545	-165 Reduced 0.86%	18,927 $971,000
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $7,815 - $8,738	-135 Reduced 0.7%	19,092 $1.11 Million
Q2 2023 Aug 23, 2023	SELL	$63.71 - $70.74 $4,523 - $5,022	-71 Reduced 0.37%	19,227 $1.23 Million
Q1 2021 May 18, 2021	BUY	$59.34 - $66.74 $14,835 - $16,685	250 Added 1.31%	19,298 $1.23 Million
Q3 2020 Nov 17, 2020	SELL	$57.43 - $63.64 $2,871 - $3,182	-50 Reduced 0.26%	19,048 $1.15 Million
Q1 2020 May 18, 2020	SELL	$46.4 - $67.43 $46,400 - $67,430	-1,000 Reduced 4.98%	19,098 $1.06 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $8,611 - $11,233	-175 Reduced 0.86%	20,098 $1.29 Million
Q4 2018 Feb 15, 2019	SELL	$48.76 - $63.23 $13,409 - $17,388	-275 Reduced 1.34%	20,273 $1.05 Million
Q2 2018 Aug 15, 2018	SELL	$50.53 - $62.98 $30,318 - $37,788	-600 Reduced 2.84%	20,548 $1.14 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $41,058 - $44,764	-685 Reduced 3.14%	21,148 $1.3 Million
Q3 2017 Nov 24, 2017	BUY	$55.23 - $63.74 $1.21 Million - $1.39 Million	21,833	21,833 $1.39 Million

Others Institutions Holding BMY

# of Institutions

2,468

Shares Held

1.5B

Call Options Held

29.6M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $116B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adalta Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adalta Capital Management LLC with notifications on news.

Account

Adalta Capital Management LLC Bristol Myers Squibb CO Transaction History